Abbott Laboratories

ABT

NYSE

Healthcare

Medical - Devices

North Chicago, IL, US114,000 employeesabbott.com

$102.91

+0.53(0.52%)

Mkt Cap $178.8B

$101.88

$138.08

52-Week Range

At a Glance

AI-generated

Abbott Laboratories reported strong financial performance for fiscal year 2025, with net sales of $44.33 billion and net earnings of $6.52 billion.

Revenue breakdown: Medical Devices (45.1%), Diagnostic Products (22.8%), Nutritional Products (19.7%).

8-K

Abbott Laboratories completed its acquisition of Exact Sciences Corporation on March 23, 2026, pursuant to the Merger Agreement dated November 19, 2025. Each share of Exact Sciences common stock was converted into the right to receive $105.00 in cash, and Exact Sciences became a direct, wholly owned subsidiary of Abbott.

$178.8B

Market Cap

$44.1B

Revenue

$6.5B

Net Income

Employees114,000

Fundamentals

How The Business Makes Money

Revenue by Segment

Medical Devices45.1%($229.0B)

Diagnostic Products22.8%($115.7B)

Nutritional Products19.7%($100.1B)

Established Pharmaceutical Products12.4%($63.2B)

Revenue by Geography

Non Us50.9%($232.5B)

US32.1%($146.7B)

All Other Countries9.8%($44.9B)

DE1.7%($7.6B)

CN1.4%($6.3B)

IN1.2%($5.4B)

CH1.2%($5.3B)

JP1%($4.4B)

GB0.8%($3.5B)

Activity

What Changed Recently

Material Agreement

Mar 8, 2026

. Entry into a Material Definitive Agreement On March 9, 2026, Abbott Laboratories (“Abbott”) completed the public offering and issuance of $20,000,000,000 aggr

Material Agreement

Feb 25, 2026

. Entry into a Material Definitive Agreement On February 23, 2026, Abbott Laboratories (“Abbott”) entered into a pricing agreement (the “Pricing Agreement”), da

Financial Results

Jan 21, 2026

Results of Operations and Financial Condition On January 22, 2026, Abbott Laboratories announced its results of operations for the fourth quarter and full year

Other Event

Mar 22, 2026

. Other Events. On March 23, 2026, Abbott Laboratories, an Illinois corporation (“Abbott”), completed the acquisition of Exact Sciences Corporation, a Delaware

Charter Amendment

Feb 19, 2026

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On February 20, 2026, Abbott’s Board of Directors amended the first sentence of Articl

Peer Companies

Company	Price	Change	Market Cap	P/E
MRKMerck & Co., Inc.	$120.61	-0.19%	$298.2B	15.8
NVSNovartis AG	$153.88	-0.77%	$297.5B	20.2
UNHUnitedHealth Group Incorp...	$277.06	+1.12%	$251.5B	20.3
TMOThermo Fisher Scientific ...	$492.92	-0.33%	$183.1B	26.8
GILDGilead Sciences, Inc.	$139.63	-0.48%	$173.3B	20.0
NVONovo Nordisk A/S	$36.90	+1.14%	$164.0B	10.3
ISRGIntuitive Surgical, Inc.	$452.40	-2.59%	$160.7B	59.4
SYKStryker Corporation	$331.73	+0.71%	$126.9B	39.2

Analyst View

Company Profile

CIK0000001800

ISINUS0028241000

CUSIP002824100

Phone224 667 6100

Address100 Abbott Park Road, North Chicago, IL, 60064-6400, US

SEC EDGAR